An international collaborative study to establish the WHO 1st international standards for C1-inhibitor, plasma and concentrate

Journal of Thrombosis and Haemostasis

Volumn 9, Issue 10, 2011, Pages 2097-2099

  Thelwell, C ^a   Rigsby, P ^b   Longstaff, C ^b  

^a Biotherapeutics Group   (United Kingdom)

^b NATIONAL INSTITUTE FOR BIOLOGICAL STANDARDS AND CONTROL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT COMPONENT C1S; COMPLEMENT COMPONENT C1S INHIBITOR; FRESH FROZEN PLASMA;

ANGIONEUROTIC EDEMA; ARTICLE; BLOOD LEVEL; COMPLEX FORMATION; ENZYME IMMUNOASSAY; ENZYME LINKED IMMUNOSORBENT ASSAY; FREEZE DRYING; HUMAN; PRIORITY JOURNAL; STANDARD; WORLD HEALTH ORGANIZATION;

COMPLEMENT C1 INHIBITOR PROTEIN; HUMANS; INTERNATIONAL COOPERATION; PLASMA; WORLD HEALTH ORGANIZATION;

EID: 80053394721     PISSN: 15387933     EISSN: 15387836     Source Type: Journal    
DOI: 10.1111/j.1538-7836.2011.04455.x     Document Type: Article

References (4)

1. Wagenaar-Bos IGA, Drouet C, Aygoeren-Pürsün E, Bork K, Bucher C, Bygum A, Farkas H, Fust G, Gregorek H, Hack CE, Hickey A, Joller-Jemelka HI, Kapusta M, Kreuz W, Longhurst H, Lopez-Trascasa M, Madalinski K, Naskalski J, Nieuwenhuys E, Ponard D, et al. Functional C1-Inhibitor diagnostics in hereditary angioedema: assay evaluation and recommendations. J Immunol Meth 2008; 338: 14.
2. Campbell PJ. International biological standards and reference preparations: II. Procedures used for the production of biological standards and reference preparations. J Biol Stand 1974; 2: 259-64.
3. Daas A. (2008). CombiStats v4.0., EDQM, Council of Europe.
4. Statistical analysis of results of biological assays and tests. 01/2008:50300 European Pharmacopoeia 6.0, EDQM; Section 5.3. p571